OCI.AS stock trades at €3.81 pre-market on 12 Feb 2026, setting the tone ahead of OCI N.V.’s earnings report due 17 Feb 2026. Investors will watch nitrogen and methanol margins and cash flow after cost pressures pushed the share from a €11.57 high to a €2.55 low over the past year. Volume is running at 734,472 shares versus an average 1,427,071, so pre-market moves may amplify when European trade opens.

Earnings outlook: OCI.AS stock and the 17 Feb catalyst

OCI N.V. reports earnings on 17 Feb 2026, the immediate catalyst for OCI.AS stock. Markets will focus on segment margins at Methanol Europe and Nitrogen Europe, and guidance on volumes and feedstock costs.

One clear short-term trigger: management commentary on ammonia export terminal utilisation and any revision to 2026 EBITDA guidance. That will shape intraday volatility in EUR on EURONEXT.

Q4 preview — revenue, EPS and valuation signals

OCI reported trailing EPS -1.31 and a negative P/E of -2.81, underlining cyclical earnings volatility. Book value per share is €8.53 and cash per share is €8.08, giving balance-sheet cushioning despite cash-flow weakness.

At €3.81 the stock trades at PB 0.51 and price-to-sales 1.73, below many specialty chemicals peers in Basic Materials. Watch gross margin and operating cash flow in the report for signs of recovery or further pressure.

Meyka AI rating and OCI.AS stock forecast

Meyka AI rates OCI.AS with a score out of 100: 68.37/100 — Grade B — HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. The rating is informational and not investment advice.

Meyka AI’s forecast model projects a monthly price of €4.26 (implied +11.94% vs €3.81) and a quarterly target of €6.51 (implied +70.87%). Forecasts are model-based projections and not guarantees.

Technical and trading setup for pre-market movers

Technical indicators show neutral momentum: RSI 46.48, MACD histogram 0.02, and ADX 12.29 indicating no strong trend. Bollinger middle band sits at €2.99, supporting current price action.

Average 50-day price is €3.20 and 200-day price is €5.10, so short-term momentum is improving but long-term downtrend remains. Traders should use tight risk limits given historical 1-year drawdown of -66.47%.

Risks and opportunities tied to OCI.AS stock

Key risks: feedstock price swings, negative operating cash flow per share -€1.86, and interest coverage at -3.33 which increases refinancing risk in a weak cycle. Debt to equity is 0.46, moderate but meaningful for a capital-intensive business.

Opportunities: strong cash per share €8.08, asset-rich balance sheet with tangible book value €8.42 per share, and strategic ties with ADNOC that can stabilise feedstock and distribution.

What to watch in pre-market and at open

Pre-market volume and any analyst notes ahead of the 17 Feb release will set the tone for the open on EURONEXT. Look for revisions to guidance, changes to dividend signals, and cash-flow commentary.

Reasonable near-term price targets for traders: conservative €3.50, base €5.00, bull €7.50. Use stop-losses and size positions relative to volatility (ATR €0.11).

Final Thoughts

OCI.AS stock at €3.81 on 12 Feb 2026 is trading into a clear event: the company’s 17 Feb earnings report. The balance sheet shows €8.08 cash per share and book value €8.53, which supports valuation while operating cash flow and margins remain the critical variables. Meyka AI’s model points to a near-term monthly level of €4.26 (+11.94%) and a quarterly scenario of €6.51 (+70.87%), but these are projections and not guarantees. For investors, the numbers say this is a stock with recovery potential if margins rebound, yet meaningful cyclical and liquidity risks persist. Monitor EBITDA guidance, feedstock cost commentary, and cash conversion for the clearest signals. For live quotes and position tracking use our AI-powered market analysis on Meyka: OCI.AS at Meyka. Sources: detailed price history and revenue context are available at Investing and StockAnalysis.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.